Literature DB >> 10642399

Integrin signaling's potential for mediating gene expression in hypertrophying skeletal muscle.

J A Carson1, L Wei.   

Abstract

Overloaded skeletal muscle undergoes dramatic shifts in gene expression, which alter both the phenotype and mass. Molecular biology techniques employing both in vivo and in vitro hypertrophy models have demonstrated that mechanical forces can alter skeletal muscle gene regulation. This review's purpose is to support integrin-mediated signaling as a candidate for mechanical load-induced hypertrophy. Research quantifying components of the integrin-signaling pathway in overloaded skeletal muscle have been integrated with knowledge regarding integrins role during development and cardiac hypertrophy, with the hope of demonstrating the pathway's importance. The role of integrin signaling as an integrator of mechanical forces and growth factor signaling during hypertrophy is discussed. Specific components of integrin signaling, including focal adhesion kinase and low-molecular-weight GTPase Rho are mentioned as downstream targets of this signaling pathway. There is a need for additional mechanistic studies capable of providing a stronger linkage between integrin-mediated signaling and skeletal muscle hypertrophy; however, there appears to be abundant justification for this type of research.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10642399     DOI: 10.1152/jappl.2000.88.1.337

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  29 in total

Review 1.  The muscle fiber type-fiber size paradox: hypertrophy or oxidative metabolism?

Authors:  T van Wessel; A de Haan; W J van der Laarse; R T Jaspers
Journal:  Eur J Appl Physiol       Date:  2010-07-03       Impact factor: 3.078

Review 2.  The emerging role of skeletal muscle oxidative metabolism as a biological target and cellular regulator of cancer-induced muscle wasting.

Authors:  James A Carson; Justin P Hardee; Brandon N VanderVeen
Journal:  Semin Cell Dev Biol       Date:  2015-12-01       Impact factor: 7.727

Review 3.  Mechanotransduction in skeletal muscle.

Authors:  Thomas J Burkholder
Journal:  Front Biosci       Date:  2007-01-01

4.  Laminin-binding integrin alpha7 is required for contractile phenotype expression by human airway myocytes.

Authors:  Thai Tran; Karen Ens-Blackie; Edward S Rector; Gerald L Stelmack; Karol D McNeill; Guido Tarone; William T Gerthoffer; Helmut Unruh; Andrew J Halayko
Journal:  Am J Respir Cell Mol Biol       Date:  2007-07-19       Impact factor: 6.914

Review 5.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

6.  The development of the myotendinous junction. A review.

Authors:  Benjamin Charvet; Florence Ruggiero; Dominique Le Guellec
Journal:  Muscles Ligaments Tendons J       Date:  2012-09-10

Review 7.  Exercise and the control of muscle mass in human.

Authors:  Marc Francaux; Louise Deldicque
Journal:  Pflugers Arch       Date:  2018-10-11       Impact factor: 3.657

8.  RhoA induction by functional overload and nandrolone decanoate administration in rat skeletal muscle.

Authors:  Joseph M McClung; Won J Lee; Raymond W Thompson; Larry L Lowe; James A Carson
Journal:  Pflugers Arch       Date:  2003-10-11       Impact factor: 3.657

9.  Hypertrophic stimulation increases beta-actin dynamics in adult feline cardiomyocytes.

Authors:  Sundaravadivel Balasubramanian; Santhosh K Mani; Harinath Kasiganesan; Catalin C Baicu; Dhandapani Kuppuswamy
Journal:  PLoS One       Date:  2010-07-12       Impact factor: 3.240

10.  Transcriptional adaptations following exercise in thoroughbred horse skeletal muscle highlights molecular mechanisms that lead to muscle hypertrophy.

Authors:  Beatrice A McGivney; Suzanne S Eivers; David E MacHugh; James N MacLeod; Grace M O'Gorman; Stephen D E Park; Lisa M Katz; Emmeline W Hill
Journal:  BMC Genomics       Date:  2009-12-30       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.